How could perampanel, a potent AMPAergic antagonist, inhibit seizures but largely spare normal neurotransmission?

Ähnliche Einträge

• Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study
  von: Chia‐Chen Hsu, et al.
  Veröffentlicht: (2025)
• Toll‐like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5‐hydroxytryptaminergic neurotransmission
  von: Sofia Faggin, et al.
  Veröffentlicht: (2025)
• The mitochondrial calcium uniporter inhibitor Ru265 increases neuronal excitability and reduces neurotransmission via off‐target effects
  von: Peng Xu, et al.
  Veröffentlicht: (2024)
• 7,4′‐dimethoxy‐3‐hydroxyflavone, a protease‐activated receptor 4 (PAR4) inhibitor with antioxidant activity, ameliorates diabetic endothelial dysfunction
  von: Ju‐Ying Tsai, et al.
  Veröffentlicht: (2025)
• Response to: Comment on ‘comparative effectiveness of clopidogrel vs . potent P2Y12 inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real‐world cohort study’
  von: Hsing‐Yu Hsu, et al.
  Veröffentlicht: (2026)